[Diabetic emergencies : Hypoglycemia, ketoacidotic and hyperglycemic hyperosmolar nonketotic coma]

Internist (Berl). 2017 Oct;58(10):1020-1028. doi: 10.1007/s00108-017-0317-x.
[Article in German]

Abstract

The diabetic emergencies diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar state (HHS) and hypoglycemia represent severe and potentially life-threatening complications of diabetes mellitus that require prompt diagnostics and treatment. Absolute or relative insulin insufficiency is characteristic of DKA und HHS along with severe dehydration. They differ by the prevalence of ketone bodies and the severity of acidosis; however, the treatment regimens are similar. In contrast, hypoglycemia is the limiting factor for achieving ambitious glucose targets. This article decribes the clinical presentation, diagnostics and emergency management of these metabolic derangements.

Keywords: Diabetes mellitus; Electrolytes; Fluid therapy; Hyperglycemic hyperosmolar nonketotic coma; Ketoacidosis, euglycemic.

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Blood Glucose / metabolism
  • Combined Modality Therapy
  • Diabetes Complications / blood
  • Diabetes Complications / diagnosis*
  • Diabetes Complications / mortality
  • Diabetes Complications / therapy
  • Diabetic Ketoacidosis / blood
  • Diabetic Ketoacidosis / diagnosis*
  • Diabetic Ketoacidosis / mortality
  • Diabetic Ketoacidosis / therapy
  • Dipeptidyl-Peptidase IV Inhibitors / adverse effects
  • Dipeptidyl-Peptidase IV Inhibitors / therapeutic use
  • Early Diagnosis
  • Early Medical Intervention
  • Emergencies*
  • Fluid Therapy
  • Humans
  • Hyperglycemic Hyperosmolar Nonketotic Coma / blood
  • Hyperglycemic Hyperosmolar Nonketotic Coma / diagnosis*
  • Hyperglycemic Hyperosmolar Nonketotic Coma / mortality
  • Hyperglycemic Hyperosmolar Nonketotic Coma / therapy
  • Hypoglycemia / blood
  • Hypoglycemia / diagnosis*
  • Hypoglycemia / mortality
  • Hypoglycemia / therapy
  • Insulin / blood
  • Retrospective Studies
  • Sodium-Glucose Transporter 2 Inhibitors / adverse effects
  • Sodium-Glucose Transporter 2 Inhibitors / therapeutic use

Substances

  • Blood Glucose
  • Dipeptidyl-Peptidase IV Inhibitors
  • Insulin
  • Sodium-Glucose Transporter 2 Inhibitors